Beauty Farm Medical and Health Industry Inc. (2373) announced the repurchase of 60,000 shares on the market on October 17, 2025, for a total transaction value of approximately HK$1,942,870 at an average price of about HK$32.38 per share. According to the announcement, between October 15, 2025, and the date of the disclosure, the company repurchased a total of 140,000 shares, amounting to around HK$4,648,710 in total consideration.

The board of directors highlights that the current trading price does not reflect the intrinsic value or business prospects of the company. The repurchase is intended to underscore management’s confidence in the enterprise’s long-term value and to enhance the group’s capital market performance while supporting shareholder returns.

The repurchase exercise was carried out under the general mandate approved at the company’s annual general meeting on June 27, 2025, authorizing up to 10% of the total issued shares to be repurchased. Potential investors and shareholders are advised that any further repurchases will depend on market conditions and remain at the discretion of the board.